Related Experiment Video
Updated: Feb 16, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Dually modified transmembrane proteoglycans in development and disease
Laura M Jenkins1, Ben Horst1, Carly L Lancaster1
1Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC, 29208, USA.
Abstract:
Aberrant cell signaling in response to secreted growth factors has been linked to the development of multiple diseases, including cancer. As such, understanding mechanisms that control growth factor availability and receptor-growth factor interaction is vital. Dually modified transmembrane proteoglycans (DMTPs), which are classified as cell surface macromolecules composed of a core protein decorated with covalently linked heparan sulfated (HS) and/or chondroitin sulfated (CS) glycosaminoglycan (GAG) chains, provide one type of regulatory mechanism. Specifically, DMTPs betaglycan and syndecan-1 (SDC1) play crucial roles in modulating key cell signaling pathways, such as Wnt, transforming growth factor-β and fibroblast growth factor signaling, to affect epithelial cell biology and cancer progression. This review outlines current and potential functions for betaglycan and SDC1, with an emphasis on comparing individual roles for HS and CS modified DMTPs. We highlight the mutual dependence of DMTPs' GAG chains and core proteins and provide comprehensive knowledge on how these DMTPs, through regulation of ligand availability and receptor internalization, control cell signaling pathways involved in development and disease.
Insights
Dually modified transmembrane proteoglycans (DMTPs) regulate cell signaling pathways crucial for development and disease, including cancer. Understanding their roles in growth factor availability and receptor interaction is vital for therapeutic strategies.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- Aberrant cell signaling drives diseases like cancer.
- Growth factor availability and receptor interactions are key regulatory mechanisms.
- Dually modified transmembrane proteoglycans (DMTPs) are cell surface macromolecules regulating these interactions.
Purpose of the Study:
- To review the functions of betaglycan and syndecan-1 (SDC1) DMTPs.
- To compare the roles of heparan sulfate (HS) and chondroitin sulfate (CS) modifications in DMTPs.
- To elucidate how DMTPs control cell signaling in development and disease.
Main Methods:
- Literature review of current research on DMTPs.
- Comparative analysis of betaglycan and SDC1 functions.
- Focus on HS and CS glycosaminoglycan (GAG) chain modifications.
Main Results:
- Betaglycan and SDC1 modulate Wnt, TGF-β, and FGF signaling pathways.
- DMTPs regulate ligand availability and receptor internalization.
- HS and CS GAG chains are mutually dependent on core proteins for function.
Conclusions:
- DMTPs are critical regulators of cell signaling pathways.
- Understanding DMTPs offers insights into cancer progression and development.
- Targeting DMTPs may present novel therapeutic avenues.
Related Concept Videos
Proteoglycans
Matrix Proteoglycans and Glycoproteins
Single-pass Transmembrane Proteins
Insertion of Single-pass Transmembrane Proteins in the RER
Integral transmembrane proteins possess transmembrane and extra membrane domains. The transmembrane domains are primarily made of 20-25 hydrophobic amino acids arranged in a helical secondary confirmation. These...
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...

